Joining the Fight Against Glioblastoma
MedTech business service provide leads commercialization of platform oncology medical device. MAE Group, a New Hampshire-based corporation, leads the commercialization of a thermobrachytherapy oncology medical device, a platform technology, under the MAE Group brand. The project entitled “Project Hope” offers hope to individuals and their families impacted by glioblastoma and other brain cancers. Although MAE
Joining the Fight Against Glioblastoma Read More »
Project Hope


